Completed IPF Study
Post authorisation Safety Study (PASS) of Esbriet® (Pirfenidone): A Prospective Observational Registry to Evaluate Long Term Safety in a Real World Setting.
Principle Investigator: Professor Gisli Jenkins
- Glenn Hearson
Post authorisation safety study of Esbriet (PASSPORT)